TAM Receptor Tyrosine Kinases: Biologic Functions, Signaling, and Potential Therapeutic Targeting in Human Cancer

Por Linger, Rachel M. A., Keating, Amy K., Earp, H. Shelton, Graham, Douglas K.
Publicado em 2008

Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors

Por Linger, Rachel M.A., Keating, Amy K., Earp, H. Shelton, Graham, Douglas K.
Publicado em 2010

Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development

Por Lee-Sherick, Alisa B., Linger, Rachel M. A., Gore, Lia, Keating, Amy K., Graham, Douglas K.
Publicado em 2010

Prolonged Exposure to a Mer Ligand in Leukemia: Gas6 Favors Expression of a Partial Mer Glycoform and Reveals a Novel Role for Mer in the Nucleus

Por Migdall-Wilson, Justine, Bates, Christine, Schlegel, Jennifer, Brandão, Luis, Linger, Rachel M. A., DeRyckere, Deborah, Graham, Douglas K.
Publicado em 2012

Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia

Por Linger, Rachel M. A., DeRyckere, Deborah, Brandão, Luis, Sawczyn, Kelly K., Jacobsen, Kristen M., Liang, Xiayuan, Keating, Amy K., Graham, Douglas K.
Publicado em 2009

Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer

Por Cummings, Christopher T., Linger, Rachel M.A., Cohen, Rebecca A., Sather, Susan, Kirkpatrick, Gregory D., Davies, Kurtis D., DeRyckere, Deborah, Earp, H. Shelton, Graham, Douglas K.
Publicado no Oncotarget (2014)

Mer or Axl Receptor Tyrosine Kinase Inhibition Promotes Apoptosis, Blocks Growth, and Enhances Chemosensitivity of Human Non-Small Cell Lung Cancer

Por Linger, Rachel M.A., Cohen, Rebecca A., Cummings, Christopher T., Sather, Susan, Migdall-Wilson, Justine, Middleton, Deryck H.G., Lu, Xian, Barón, Anna E., Franklin, Wilbur A., Merrick, Daniel T., Jedlicka, Paul, DeRyckere, Deborah, Heasley, Lynn E., Graham, Douglas K.
Publicado em 2012

Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia

Por Linger, Rachel M. A., Lee-Sherick, Alisa B., DeRyckere, Deborah, Cohen, Rebecca A., Jacobsen, Kristen M., McGranahan, Amy, Brandão, Luis N., Winges, Amanda, Sawczyn, Kelly K., Liang, Xiayuan, Keating, Amy K., Tan, Aik Choon, Earp, H. Shelton, Graham, Douglas K.
Publicado em 2013